Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-15-028607)

Filing Details

Accession Number:: 0001209191-15-028607
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-03-23 18:53:35
Reporting Period:: 2015-03-19

Filing Date:: 2015-03-23
Accepted Time:: 2015-03-23 18:53:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1411158	Anacor Pharmaceuticals Inc.	ANAC	Pharmaceutical Preparations (2834)	251854385

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1202769	L Paul Berns	C/O Anacor Pharmaceuticals, Inc. 1020 East Meadow Circle Palo Alto CA 94303	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-03-19	37,500	$56.07	308,760	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This sale was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person to cover taxes associated with the vesting of restricted stock units.
The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $55.455 to $56.45, inclusive.